Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
257 participants
OBSERVATIONAL
2008-08-31
2009-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group1
continuous volatile anesthesia (sevoflurane) during the liver resection
No interventions assigned to this group
group2
continuous intravenous anesthesia (propofol) during the liver resection
No interventions assigned to this group
group3
preconditioning volatile anesthesia (sevoflurane) 30 minutes before ischemia (inflow occlusion)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* benign and malign disease
* any type of liver surgery
* inflow occlusion during the liver surgery
Exclusion Criteria
* participation on other interventional and treatment randomized controlled trials,
* trauma of the liver
* liver cirrhosis
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Visceral and Transplantation Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ksenija Slankamenac, med. pract
Role: PRINCIPAL_INVESTIGATOR
Departement of Visceral and Transplantation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universtiy Hospital of Zurich, Department of Visceral and Transplantation Surgery
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
StV 18-2008
Identifier Type: -
Identifier Source: org_study_id